FierceBiotech1d
Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes
Novo Nordisk is doubling down on its collaboration with Valo Health, committing up to $190 million in near-term payments—and ...
The Motley Fool20d
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
Bad news for Novo Nordisk (NVO-1.99%) Friday was good news for Eli Lilly (LLY 1.07%) and Viking Therapeutics (VKTX-2.05%), its two main rivals in the field of weight loss drugs. This morning ...
FierceBiotech2d
Novo Nordisk and Variant set out to find new metabolic treatments, pay communities that share genetic data
Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populatio | ...
pharmaphorum9d
Novo Nordisk: survival of the fittest applies in diabetes and obesity market
Diabetes specialist Novo Nordisk is feeling the heat from increasingly ... Reimagining What's Possibl In a new white paper from the World Without Disease initiative, a 2024 update is provided ...
Reuters24d
Novo Nordisk invests $1.2 bln in new rare disease drugs plant in Denmark
STOCKHOLM/LONDON, Dec 16 (Reuters) - Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the production of rare disease drugs ...